Earnings History Data for Prelude Therapeutics (PRLD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Prelude Therapeutics
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company. It is focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorporated is based in Wilmington, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-11-2023 | AH | PRLD | Prelude Therapeutics | 98.00 | -0.45 | -0.58 | 0.00 | 2.21 | 0.35 (18.82%) |
2.21 | 0.0 (0.00%) |
1.66 - 8.66 | 3,063,060 | 100,000 | 1,105 | |||
|
|
||||||||||||||||||
| 03-08-2023 | PM | PRLD | Prelude Therapeutics | 177.00 | -0.54 | -0.65 | 0.00 | Prelude Therapeutics GAAP EPS of -$0.54 [8/3/2023 10:07 AM] |
3.61 | -0.14 (-3.73%) |
3.81 | 0.06 (1.60%) |
3.50 - 8.90 | 82,738 | 100,000 | 105 | ||
| 08-05-2023 | PM | 8:00 AM ET (May 8) |
PRLD | Prelude Therapeutics | 292.00 | -0.58 | -0.68 | 0.00 | Prelude Therapeutics GAAP EPS of -$0.58 beats by $0.10 [5/8/2023 8:43 AM] |
6.32 | -0.19 (-2.92%) |
0.0 | 0.0 (0.00%) |
3.87 - 8.90 | 32,064 | 50,000 | 0 | |
| 09-08-2022 | PM | 0:00 AM ET (Aug 9) |
PRLD | Prelude Therapeutics | 294.00 | -0.58 | -0.60 | 0.00 | Prelude Therapeutics GAAP EPS of -$0.58 [8/9/2022 8:34 AM] |
6.50 | -0.05 (-0.76%) |
6.56 | 0.01 (0.15%) |
3.87 - 43.55 | 183,866 | 80,000 | 1,000 | |
| 16-03-2022 | PM | 8:00 AM ET (Mar 16) |
PRLD | Prelude Therapeutics Incorporated | 420.22 | -0.71 | -0.69 | -0.45 | Prelude Therapeutics GAAP EPS of -$2.43 misses by $0.01 [3/16/2022 8:00 AM] |
7.73 | 0.58 (8.11%) |
7.00 | -0.15 (-2.10%) |
6.76 - 60.39 | 304,966 | 334,286 | 688 | |
| 12-11-2021 | PM | PRLD | Prelude Therapeutics | 808.00 | -0.66 | -0.62 | 0.00 | Prelude Therapeutics EPS misses by $0.02 [11/12/2021 8:35 AM] |
16.20 | -0.56 (-3.34%) |
16.62 | -0.14 (-0.84%) |
15.31 - 95.38 | 237,279 | 200,000 | 629 | ||
| 12-08-2021 | PM | 7:30 AM ET (Aug 12) |
PRLD | Prelude Therapeutics Incorporated | 1,501 | -0.58 | -0.51 | 0.00 | Prelude Therapeutics EPS misses by $0.06 [8/12/2021 8:08 AM] |
34.19 | 0.21 (0.62%) |
34.19 | 0.0 (0.00%) |
23.69 - 95.38 | 94,197 | 180,000 | 1,063 | |
| 11-05-2021 | PM | 8:00 AM ET (May 11) |
PRLD | Prelude Therapeutics Incorporated | 1,477 | -0.47 | -0.41 | 0.00 | Prelude Therapeutics EPS misses by $0.05 [5/11/2021 8:23 AM] |
41.18 | 0.48 (1.18%) |
41.18 | 0.0 (0.00%) |
23.69 - 95.38 | 210,027 | 210,000 | 510 | |
| 16-03-2021 | PM | PRLD | Prelude Therapeutics Incorporated | 2,670 | -0.45 | -0.52 | 0.00 | Prelude Therapeutics EPS beats by $0.13 [3/16/2021 9:31 AM] |
55.88 | -1.94 (-3.35%) |
58.00 | 0.19 (0.33%) |
23.69 - 95.38 | 98,417 | 105,380 | 100 | ||